Tag:
STA-9090
Latest Headlines
Latest Headlines
Synta's billion-dollar drug nears end of Phase III
Synta Pharmaceuticals has reached a key point in its development of the cancer therapy elesclomol . The developer is set to announce today that it has completed enrollment in a confirmatory Phase III
